MedTrace Logo

Predicting Long-term Outcomes After Cardiac Arrest by Using Serum NGAL

NCT03615300 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2024-05-13

No results posted yet for this study

Summary

This study was performed to determine the prognosis of patients after cardiac arrest using serum markers called NGAL. The initial NGAL values of patients with post-cardiac arrest syndrome are checked by blood tests, and the long-term neurological prognosis and survival rate are collected after 6 months.

Conditions

  • Out-of-Hospital Cardiac Arrest

Interventions

DIAGNOSTIC_TEST

serum NGAL

serum NGAL was measured at 0, 24, 48, and 72 hours after recovery of spontaneous circulation.

Sponsors & Collaborators

  • Uijeongbu St. Mary Hospital

    lead OTHER

Principal Investigators

  • Joo Suk Oh, MD PhD · The Catholic University of Korea, Uijeongbu ST. Mary's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-28
Primary Completion
2022-05-01
Completion
2022-05-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03615300 on ClinicalTrials.gov